Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Effectiveness and Safety of Sustained-Release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.
This study has been completed.
Study NCT00261495   Information provided by Janssen Pharmaceutica N.V., Belgium
First Received: December 2, 2005   Last Updated: July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain
Interventions listed in this trial
Oxycodone
OROS hydromorphone HCl
Additional drug interventions recognized in this trial
Analgesics, Opioid
Hydromorphone
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Janssen Pharmaceutica N.V., Belgium


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services